Weekly Round Up

Research Deep DiveLong Form ArticleWeekly Round Up
Weekly Round UpWeekly Round Up
$9.9M HIPAA Fines, 50% Integration Pain, 78% Betting On AI

$9.9M HIPAA Fines, 50% Integration Pain, 78% Betting On AI

78% of leaders turn to AI for efficiency and $9.9M in HIPAA fines signals tougher enforcement, while integration complexity stalls virtual care for 50%.

Weekly Round UpWeekly Round Up
Healthcare M&A Under Pressure, Gavi Funding at Risk, and the Rise of Personalized Medicine

Healthcare M&A Under Pressure, Gavi Funding at Risk, and the Rise of Personalized Medicine

The U.S. conditions Gavi funding on thimerosal elimination and North America holds 45% of the personalized medicine market, while integration risk tops M&A concerns.

Weekly Round UpWeekly Round Up
Healthcare’s New Reality: $191B Deals, 61% More M&A, Rising Scrutiny

Healthcare’s New Reality: $191B Deals, 61% More M&A, Rising Scrutiny

Digital health funding rebounds 35% and 74% cite innovation as the top cost driver, while regulators target pharmacy supply chains.

Weekly Round UpWeekly Round Up
FDA–EMA Alignment, FemTech’s Regional Divide, and a $14.5B MedTech Bet

FDA–EMA Alignment, FemTech’s Regional Divide, and a $14.5B MedTech Bet

Boston Scientific acquires Penumbra for $14.5B and North America leads FemTech with 39% market share, while regulators set joint AI principles.

Weekly Round UpWeekly Round Up
Pharma’s 10.7% Bounce, AI’s 75% Promise & Rising $ Pressure

Pharma’s 10.7% Bounce, AI’s 75% Promise & Rising $ Pressure

After a 5-year lag, Pharma rebounds with 10.7% TSR while 23 states target drug pricing and 75% of leaders eye AI for admin efficiency.

Weekly Round UpWeekly Round Up
From HealthTech Deals to Mega Mergers: This Week in Healthcare

From HealthTech Deals to Mega Mergers: This Week in Healthcare

HealthTech M&A separates the scalable from the speculative and policy shifts top the 2026 agenda, while NYC sees a $2.2B hospital merger.

Weekly Round UpWeekly Round Up
What’s Holding Healthcare Back from AI Adoption?

What’s Holding Healthcare Back from AI Adoption?

This week we’re exploring the main barriers in AI adoption among Healthcare Systems.

Weekly Round UpWeekly Round Up
End of Year Special Issue: A 2025 Review and key Topics for 2026 in Healthcare

End of Year Special Issue: A 2025 Review and key Topics for 2026 in Healthcare

Biotech is projected to cross $2.19T and wearables hit a strategic inflection point, while only 10% of systems report significant AI returns.

Weekly Round UpWeekly Round Up
Beyond the Hype: What Health Systems are Actually Buying for 2026

Beyond the Hype: What Health Systems are Actually Buying for 2026

Hospitals hold 27% of the RCM market and BMS invests $1.5B in CAR T, while 77% of systems stall AI adoption due to maturity issues.

Weekly Round UpWeekly Round Up
75% of Leaders Back AI for Admin, While Biotech Leaves EU 40% Behind

75% of Leaders Back AI for Admin, While Biotech Leaves EU 40% Behind

Precision medicine targets $470B and Sobi bets $1.5B on gout, while small molecules drop to 53% of Phase III trials.

Weekly Round UpWeekly Round Up
FemTech to $130B, a $2B MedTech Move, and a 65% Drop in Late-Stage VC

FemTech to $130B, a $2B MedTech Move, and a 65% Drop in Late-Stage VC

FemTech targets a $130B valuation and Teleflex executes $2B in strategic carve-outs, while late-stage HealthTech funding drops 65% amid a widening global confidence gap.

Weekly Round UpWeekly Round Up
$850B WellTech Boom, $1B Exit, and the New Rules Reshaping U.S. Healthcare

$850B WellTech Boom, $1B Exit, and the New Rules Reshaping U.S. Healthcare

UnitedHealth finalizes its Latin America retreat with a $1B sale to Patria as WellTech surges to an $850B opportunity, while 46 states race to regulate the growing AI adoption gap.